- CEO
- Manivannan Selvaraj
- Full Time Employees
- 1,695
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- 6, Royal Road Trichy TN India 620001
- IPO Date
- Jul 6, 1992
- Business
- KMC Speciality Hospitals (India) Limited, a subsidiary of Sri Kauvery Medical Care (India) Limited, operates a multi-specialty super-specialty hospital in Tiruchirappalli, India, providing comprehensive medical and healthcare services across numerous disciplines including heart and lungs transplantation, pleural diseases, cardiology, neurology and neuroscience, general medicine, diabetology, orthopedics, spine surgery, gastroenterology, diagnostic and interventional radiology, geriatrics, nephrology and urology, oncology, pediatrics and neonatology, infectious diseases, plastic surgery, breast clinics, vascular surgery, liver diseases, transplantation, hepatobiliary surgery, anesthesiology, critical care, dental and maxillofacial, dermatology, ophthalmology, endocrinology, ENT head and neck surgery, general surgery, obstetrics and gynecology, psychiatry, pulmonology, rheumatology, and specialty clinics for pediatric, obstetric, family planning, and gynec services as well as cervical cancer screening and laboratory services; the company primarily serves inpatients and outpatients in the healthcare sector with a focus on secondary and tertiary care. Incorporated in 1982 and headquartered at No. 6, Royal Road, Cantonment, Tiruchirappalli, Tamil Nadu, it forms part of the Kauvery Hospitals group, which maintains over 2,250 beds across multiple locations in India including Trichy, Chennai, Salem, Hosur, Tirunelveli, and Bengaluru, targeting patients requiring advanced treatments such as transplants, joint replacements, and kidney procedures. In September 2025, the company acquired a 26% stake in Gardenia Energy Private Limited for INR 26,000 to secure solar power as a captive consumer for its MAA Kauvery Hospital unit, aiming to reduce energy costs and enhance sustainability; it also held its annual general meeting in September 2025, adopting financial statements for the year ended March 31, 2025, reappointing directors, approving related party transactions with its holding company, and appointing a secretarial auditor.